Public health and private equity: What the Walgreens buyout could mean for the future of pharmacy care

The Conversation
Written by St. Paul Corner Drug (SPCD)

Sycamore Partners’ March acquisition of Walgreens raises big questions. What does Sycamore see in this investment, and what might their strategies imply about the future of American pharmacy care?

Read the article here
St. Paul Corner Drug (SPCD)
Previous

PBM Legislation in the Reconciliation Bill is Far From Sweeping PBM Reform
Next

Jury Awards Major Damages Against Omnicare and CVS Health